These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 31780139)

  • 21. Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex.
    Murphy GS; Avram MJ; Greenberg SB; Bilimoria S; Benson J; Maher CE; Teister KJ; Szokol JW
    Anesth Analg; 2021 Aug; 133(2):435-444. PubMed ID: 33323787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of neuromuscular blockade with sugammadex or neostigmine/atropine: Effect on postoperative gastrointestinal motility.
    Sen A; Erdivanli B; Tomak Y; Pergel A
    J Clin Anesth; 2016 Aug; 32():208-13. PubMed ID: 27290978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Functional respiratory imaging after neostigmine- or sugammadex-enhanced recovery from neuromuscular blockade in the anesthetised rat: a randomised controlled pilot study].
    Schepens T; Cammu G; Maes S; Desmedt B; Vos W; Deseure K
    Rev Bras Anestesiol; 2017; 67(5):443-449. PubMed ID: 28526472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-operative urinary retention is impacted by neuromuscular block reversal agent choice: A retrospective cohort study in US hospital setting.
    Bash LD; Turzhitsky V; Mark RJ; Hofer IS; Weingarten TN
    J Clin Anesth; 2024 May; 93():111344. PubMed ID: 38007845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex.
    Oh TK; Ji E; Na HS
    Medicine (Baltimore); 2019 Jun; 98(26):e16142. PubMed ID: 31261539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer.
    Yu Y; Wang H; Bao Q; Zhang T; Chen B; Ding J
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3626-3633. PubMed ID: 35662514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative residual neuromuscular blockade after reversal based on a qualitative peripheral nerve stimulator response: A randomised controlled trial.
    Lee YJ; Oh AY; Koo BW; Han JW; Park JH; Hong JP; Seo KS
    Eur J Anaesthesiol; 2020 Mar; 37(3):196-202. PubMed ID: 31977627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
    Aouad MT; Alfahel WS; Kaddoum RN; Siddik-Sayyid SM
    BMC Anesthesiol; 2017 Apr; 17(1):57. PubMed ID: 28399799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of neuromuscular block with neostigmine versus sugammadex: comment on Br J Anaesth 2021; 127: 316-23.
    Powell L; Kidd L
    Br J Anaesth; 2022 Jul; 129(1):e8-e10. PubMed ID: 35469673
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study.
    Colquhoun DA; Vaughn MT; Bash LD; Janda A; Shah N; Ghaferi A; Sjoding M; Mentz G; Kheterpal S;
    Br J Anaesth; 2023 Jan; 130(1):e148-e159. PubMed ID: 35691703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block.
    Martini CH; Boon M; Bevers RF; Aarts LP; Dahan A
    Br J Anaesth; 2014 Mar; 112(3):498-505. PubMed ID: 24240315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative pulmonary complications after sugammadex reversal of neuromuscular blockade: a systematic review and meta-analysis with trial sequential analysis.
    Liu HM; Yu H; Zuo YD; Liang P
    BMC Anesthesiol; 2023 Apr; 23(1):130. PubMed ID: 37081384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Anaesthesia; 2018 May; 73(5):631-641. PubMed ID: 29280475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.